Recruiting Migraine Studies in Culver City
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
The purpose of this study is to test the safety and efficacy of BHV-3000 versus placebo in the acute treatment of moderate or severe migraine in children and adolescents....
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
The purpose of this study is to test the long-term safety of rimegepant in the acute treatment of migraine in children and adolescents (≥ 6 to \< 18 years of age)....
About Migraine Clinical Trials in Culver City
Migraine is a neurological condition characterized by intense, debilitating headaches often accompanied by nausea, light sensitivity, and visual disturbances. It affects about 1 billion people globally and is a leading cause of disability. Treatments include preventive medications, acute therapies, and newer CGRP-targeting drugs.
There are currently 2 migraine clinical trials recruiting participants in Culver City, CALIFORNIA. These studies are seeking a combined 2,700 participants. Research is being sponsored by Pfizer. Clinical trial participation is free and participants receive study-related medical care at no cost.
Migraine Clinical Trials in Culver City — FAQ
Are there migraine clinical trials in Culver City?
Yes, there are 2 migraine clinical trials currently recruiting in Culver City, CALIFORNIA. Browse the studies on this page to find one that fits.
How do I join a clinical trial in Culver City?
Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Culver City research site will contact you about next steps.
Are clinical trials in Culver City free?
Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Culver City studies also compensate for your time and travel.
What migraine treatments are being tested?
The 2 active trials in Culver City are testing new therapies including novel drugs, biologics, and treatment approaches for migraine.
Data updated March 2, 2026 from ClinicalTrials.gov